KWM
ALIM

Kingsview Wealth Management’s Alimera Sciences ALIM Stock Holding History

Kingsview Wealth Management’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,989
Closed -$17K – 536
2019
Q3 		$17K Sell
1,989
-800
-29% -$7.27K ﹤0.01% 416
2019
Q2 		$37K Sell
2,789
-333
-11% -$4.69K 0.01% 409
2019
Q1 		$50K Buy
+3,122
New +$47.5K 0.01% 442

Other funds holding ALIM

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Kingsview Wealth Management's ALIM Position: Q4 2019 in Review

Kingsview Wealth Management sold out of Alimera Sciences (ALIM) in Q4 2019, closing a stake of 1,989 shares — an estimated $17K sold.

Kingsview Wealth Management first reported a position in ALIM in Q1 2019 and held it in 3 quarters. The position peaked at $50K in Q1 2019. 22 funds tracked by Wall St. Rank hold ALIM as of Q4 2019.

  • Kingsview Wealth Management reported no remaining Alimera Sciences position as of Q4 2019 after selling out during the quarter.
  • Kingsview Wealth Management sold 1,989 Alimera Sciences shares in Q4 2019, an estimated $17K.
  • Kingsview Wealth Management first reported a position in Alimera Sciences in Q1 2019 and held it in 3 quarters.
  • Kingsview Wealth Management's Alimera Sciences position peaked at $50K in Q1 2019.
  • 22 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2019.

Based on Kingsview Wealth Management's 13F filing for Q4 2019, filed 30 Jan 2020.